Unknown

Dataset Information

0

Effect of S267F variant of NTCP on the patients with chronic hepatitis B.


ABSTRACT: Sodium taurocholate cotransporting polypeptide (NTCP) was identified as an entry receptor for hepatitis B virus (HBV) infection. The substitution of serine at position 267 of NTCP with phenylalanine (S267F) is an Asian-specific variation that hampers HBV entry in vitro. In this study, we aimed to evaluate the prevalence of S267F polymorphism in Korean patients with chronic hepatitis B (CHB) and its association with disease progression and potential viral evolution in the preS1 domain of HBV. We found that the frequency of the S267F variant of NTCP in CHB patients and controls was 2.7% and 5.7% (P?=?0.031), respectively, and that those who had S267F variant were less susceptible to chronic HBV infection. The frequency of the S267F variant in CHB, cirrhosis and hepatocellular carcinoma (HCC) patients was 3.3%, 0.9%, and 3.5%, respectively. Thus, the S267F variant correlated significantly with a lower risk for cirrhosis (P?=?0.036). Sequencing preS1 domain of HBV from the patients who had S267F variant revealed no significant sequence change compared to the wild type. In conclusion, the S267F variant of NTCP is clinically associated with a lower risk of chronic HBV infection and cirrhosis development, which implicates suppressing HBV entry could reduce the disease burden.

SUBMITTER: Lee HW 

PROVIDER: S-EPMC5732244 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of S267F variant of NTCP on the patients with chronic hepatitis B.

Lee Hye Won HW   Park Hye Jung HJ   Jin Bora B   Dezhbord Mehrangiz M   Kim Do Young DY   Han Kwang-Hyub KH   Ryu Wang-Shick WS   Kim Seungtaek S   Ahn Sang Hoon SH  

Scientific reports 20171215 1


Sodium taurocholate cotransporting polypeptide (NTCP) was identified as an entry receptor for hepatitis B virus (HBV) infection. The substitution of serine at position 267 of NTCP with phenylalanine (S267F) is an Asian-specific variation that hampers HBV entry in vitro. In this study, we aimed to evaluate the prevalence of S267F polymorphism in Korean patients with chronic hepatitis B (CHB) and its association with disease progression and potential viral evolution in the preS1 domain of HBV. We  ...[more]

Similar Datasets

| S-EPMC8608598 | biostudies-literature
| S-EPMC5571206 | biostudies-literature
| S-EPMC8476618 | biostudies-literature
| S-EPMC6095921 | biostudies-literature
| S-EPMC6407604 | biostudies-literature
| S-EPMC9817056 | biostudies-literature
| S-EPMC7943921 | biostudies-literature
| S-EPMC6749789 | biostudies-literature
| S-EPMC7172969 | biostudies-literature
| S-EPMC7333392 | biostudies-literature